Concord Biotech Limited has informed the Exchange regarding ' Successful Completion Of NAFDAC Inspection'.
CONCORDBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Concord Biotech has successfully cleared an inspection conducted by NAFDAC, the Nigerian food and drug regulatory authority. This is a regulatory milestone that confirms the company's manufacturing facilities and/or products meet Nigerian quality and safety standards. Clearance from NAFDAC allows Concord Biotech to continue supplying pharmaceutical products in the Nigerian market. The inspection outcome reflects positively on the company's compliance and quality systems.
Positive for shareholders — this regulatory clearance supports continued business in Nigeria, a key African market, and strengthens the company's export footprint. No immediate financial figures were disclosed with this update.